Diamant Thaçi

56PUBLICATIONS
182CO-AUTHORS
PharmacogenomicsEpidemiological methodsNutrigenomics and personalised nutritionGene and molecular therapyMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (56)

|Aug 07, 2026
Deucravacitinib 5-Year Safety and Efficacy Results in Plaque Psoriasis: A Phase 3 Open-Label Extension of Randomized Clinical Trials.

|Jul 06, 2026
Psychiatric Risk in Chronic Spontaneous Urticaria: A Retrospective Cohort Study.

|Jun 30, 2026
Efficacy of digital therapeutic sinCephalea for personalised nutrition versus control for migraine prevention: A 12-week open-label randomised clinical trial.

|May 29, 2026
Repeated switching between biosimilar ABP 654 and reference ustekinumab in patients with moderate-to-severe plaque psoriasis: a randomized, double-blinded clinical trial to support interchangeability.

|May 21, 2026
Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials.

|Apr 13, 2026
Patients with Atopic Dermatitis and Insufficient Response to Conventional Systemic Therapy in Germany: A Health Claims Data Analysis.

Carolina Schwedhelm, Leonie Kunk, Dorota Pawlowska-Phelan

Pageof 10

Frequent Collaborators

7 joint publications

Richard G Langley

7 joint publications

Kim Papp

6 joint publications

Henning Olbrich

6 joint publications

Bruce Strober